Active Ingredient: CLONIDINE HYDROCHLORIDE
Proprietary Name: ONYDA XR
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; ORAL
Strength: 0.1MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217645
Product Number: 001
Approval Date: May 24, 2024
Applicant Holder Full Name: TRIS PHARMA INC
Marketing Status:
Prescription
Patent and Exclusivity Information